GlassScriptPhysician profile
Dilpreet Singh
NPI 1194188540
$15,030.21
in general payments reported to CMS, 2019-2025
25 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $105 · 2021: $923 · 2022: $5,449 · 2023: $6,361 · 2024: $1,749 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,001 · Travel and Lodging: $2,978 · Food and Beverage: $2,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,001.00 |
| Travel and Lodging | $2,977.81 |
| Food and Beverage | $2,385.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,449.98 | 2022-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $3,112.45 | 2019-2022 | |
| Intuitive Surgical, INC. | $3,000.00 | 2023 | Ion |
| Boston Scientific Corporation | $1,242.05 | 2022-2025 | Versacross Access Solution, Watchman Flx, Avvigo Guidance System |
| Astrazeneca Pharmaceuticals LP | $746.45 | 2021-2024 | Farxiga, Brilinta |
| Medtronic, INC. | $717.52 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Bard Peripheral Vascular, INC. | $353.70 | 2021-2022 | |
| Amgen INC. | $295.97 | 2022-2024 | Repatha |
| Teleflex LLC | $205.37 | 2022-2023 | Turnpike |
| Astellas Pharma US INC | $198.00 | 2021 | |
| Abiomed | $146.54 | 2020-2024 | Impella |
| Shockwave Medical, INC | $114.41 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $87.57 | 2019 | |
| Pfizer INC. | $50.83 | 2022-2023 | |
| Cardiva Medical, INC. | $41.44 | 2023 | Cardiva Vascade 6/7f Vcs |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $40.01 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $38.87 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $33.48 | 2019-2022 | |
| Cordis US Corp. | $28.00 | 2023 | Rain Sheath Transradial |
| Catalyst Pharmaceuticals, INC. | $25.87 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.36 | 2022-2025 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $23.72 | 2024 | |
| Merck Sharp & Dohme LLC | $22.99 | 2024 | Verquvo |
| Silk Road Medical, INC. | $16.82 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Terumo Medical Corporation | $13.81 | 2024 | Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dilpreet Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.